Streetbeat News

Products Services

AMZN

BBAI

BigBear.Ai Inc (NYSE:BBAI) announced an expanded partnership with Amazon.com Inc (NASDAQ:AMZN) to deliver AI-driven solutions through Amazon Web Services (AWS). The collaboration allows AWS ProServe customers to access BigBear's ProModel AI-driven warehousing solutions. BigBear.ai's CEO highlighted the importance of AI in supply chains and logistics, especially in volatile times. The company aims to grow its commercial enterprise sector capabilities. BigBear.ai's stock saw a slight increase to $1.80 before settling at $1.76, up 1.15%.

Portfolio Pulse from Adam Eckert

December 11, 2023 | 4:58 pm

KTTA

Pasithea Therapeutics' stock price is on the rise following the announcement of positive preclinical efficacy data for their drug PAS-004, which targets NRAS mutation cancer xenograft models.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:57 pm

AMD

GOOGL

U.S. stock markets showed mixed results with slight gains in major indexes. Nonfarm payrolls exceeded expectations, lowering unemployment to 3.7%. Consumer sentiment hit a high due to lower inflation concerns. European markets grew, anticipating central bank rate cuts. ECB officials hinted at possible rate reductions in 2024. German economic indicators were weak, while the UK construction sector struggled. Asian markets fell, with Japan's Nikkei and China's Shanghai Composite declining. Moody's downgraded China's outlook to negative. Alphabet and AMD stocks rose on AI developments. U.S. Treasury yields increased, while commodities like gold and oil closed lower.

Portfolio Pulse from Xclusive Trading

December 11, 2023 | 4:54 pm

KROS

Keros Therapeutics' stock price has declined following the presentation of clinical data from its KER-050 program at the 65th ASH Annual Meeting and Exposition.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:39 pm

BPMC

Blueprint Medicines' stock is trading higher following the company's announcement of new data that emphasizes its dedication to improving the scientific knowledge and treatment options for systemic mastocytosis.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:38 pm

COGT

Cogent Biosciences Inc (NASDAQ:COGT) reported positive results from its Phase 2 APEX trial for bezuclastinib in treating advanced systemic mastocytosis (AdvSM), with a strong safety profile and high overall response rates. Despite these positive clinical updates, COGT shares fell by 51.03% to $4.23. The company continues to enroll for Part 2 of the APEX trial and the SUMMIT Phase 2 trial for nonadvanced systemic mastocytosis (NonAdvSM), with completion expected by the end of 2024.

Portfolio Pulse from Vandana Singh

December 11, 2023 | 4:37 pm

MOR

MorphoSys shares are up following positive results from the Phase 3 MANIFEST-2 study of pelabresib with ruxolitinib in myelofibrosis patients.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:32 pm

BMEA

Biomea Fusion, Inc. (NASDAQ:BMEA) shares have declined by nearly 40% over the past five days, continuing a downward trend. The company presented clinical data for BMF-219 at the American Society of Hematology Annual Meeting and will detail Phase II study results in March 2024. Despite meaningful HbA1c reductions in patients, the stock has attracted significant short interest, with 44.9% of BMEA shares sold short.

Portfolio Pulse from Erica Kollmann

December 11, 2023 | 4:30 pm

OXY

Occidental Petroleum Corporation has projected a decade of oil development in the Permian Basin, with plans to utilize five rigs for the operation. This long-term outlook underscores the company's commitment to the region and indicates a steady pace of production.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 4:20 pm

PSTX

RHHBY

Poseida Therapeutics Inc (PSTX) reported positive early results from a Phase 1 study of P-BCMA-ALLO1, a CAR-T therapy candidate for multiple myeloma, in partnership with Roche Holdings AG (RHHBY). The study showed an 82% overall response rate, with high rates of partial and complete responses and well-tolerated safety profile. The news has led to a 20.6% increase in PSTX shares in premarket trading.

Portfolio Pulse from Vandana Singh

December 11, 2023 | 4:17 pm